作者: Yoshihiro Mori , Yasuhiro Nishikawa , Tomoko Iizuka , Natsuko Zenimura , Takuyuki Matsumoto
DOI: 10.2165/11592450-000000000-00000
关键词: Drug 、 Hypertension diagnosis 、 Treatment outcome 、 Drug toxicity 、 Surgery 、 Creatinine blood 、 Case report form 、 Family medicine 、 Hypertension complications 、 Medicine 、 Carvedilol
摘要: Background: In Japan, when pharmaceutical companies launch a new drug, they are obligated to conduct post-marketing survey evaluate the safety and efficacy of drug in accordance with Good Post-Marketing Surveillance Practice under Article 14-4 (re-examination) Pharmaceutical Affairs Law at contracted medical institutions. We report results long-term special that we conducted as survey.